Orchestra BioMed Holdings, Inc. (OBIO)

Last Closing Price: 4.90 (2026-09-01)

Free Cash Flow (Quarterly)

Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)

Orchestra BioMed Holdings, Inc. (OBIO) had Free Cash Flow of $-41.94M for the most recently reported fiscal quarter, ending 2026-06-30.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
$0.09M
$-24.08M
$0.03M
$0.06M
$22.44M
$-22.36M
$-1.40M
$-23.75M
$-23.80M
$-23.75M
$-23.75M
$-23.75M
$-23.80M
$-22.36M
$-22.20M
63.81M
63.81M
$-0.38
$-0.38
Balance Sheet Financials
$111.24M
$2.04M
$4.46M
$115.70M
$13.47M
$34.84M
$82.91M
$96.38M
$19.32M
$19.32M
$19.32M
60.10M
Cash Flow Statement Financials
$-41.50M
$-12.99M
$40.27M
$34.69M
$20.47M
$-14.22M
$5.36M
--
--
Fundamental Metrics & Ratios
8.26
--
--
0.64
1.80
71.59%
-25404.55%
-25404.55%
--
-26994.32%
-27362.50%
Free Cash Flow
$-41.94M
--
--
--
0.00
0.10
1.73
52.16
-122.94%
-122.94%
-20.53%
-43.86%
$0.32
$-0.66
$-0.65